Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

ShoreCap upgrades Frontier Developments to 'buy'

(Sharecast News) - Analysts at ShoreCap upgraded their recommendation for shares of Frontier Developments from 'hold' to 'buy', citing the shares' valuation and progress on its shift back to its core strength. The upgrade followed a trading update from the video game developer and publisher that same morning.

In it, the company said that sales during the initial launch of its Planet Zoo game had beaten those for the Planet Coaster console launch.

Frontier Developments also announced the sale of the publishing rights to RollerCoaster Tycoon 3 to Atari for $7m.

That led ShoreCap to bump up its estimate for the outfit's full-year 2024 earnings before interest, taxes, depreciation and amortisation from -£19m to -£15m.

Frontier's board also reiterated guidance for full-year sales of £80-95m.

ShoreCap was still anticipating revenues of only £83m but said that it now saw scope for revenues in the middle of that range if sales momentum kept up.

"Given the low EV/Sales multiple, less than 1x, and considering the initial progress as the Group's focus returns to its core strength within creative management simulation games which could see incremental revenue contributions to our forecasts, we upgrade our recommendation from Hold to Buy."

Share this article

Related Sharecast Articles

Goldman Sachs downgrades SSP to 'sell', prefers WH Smith
(Sharecast News) - Goldman Sachs downgraded SSP on Monday to 'sell' from 'neutral' "on a relative basis" as it took a look at European travel concessions.
UBS to book $900m provision over Greensill supply financing funds
(Sharecast News) - Swiss banking giant UBS announced on Monday that it expected to book a provision of about $900m related to Credit Suisse's funds, tied to the collapsed supply chain financing firm Greensill Capital.
Citi downgrades European equities to 'neutral'
(Sharecast News) - Citi downgraded its stance on European equities on Monday to 'neutral' from 'overweight' as it said near-term risks have increased, with markets narrowing and political uncertainty taking centre stage.
Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.